Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 9/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | RARB | P10826 | 1/20 | 0.31 |
| ▸ | RARG | P13631 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16231491 | 0.95 | PDK2 (0.38) | PDK2CYP1A2 | |
| SCHEMBL12781884 | 0.94 | PDK2 (0.38) | PDK2RXFP1 | |
| SCHEMBL12785881 | 0.91 | PDK2 (0.31) | PDK2 | |
| SCHEMBL12785897 | 0.85 | PDK2 (0.32) | PDK2 | |
| SCHEMBL2965134 | 0.84 | PDK2 (0.44) | PDK2 | |
| SCHEMBL12442306 | 0.82 | PDK2 (0.36) | PDK2 | |
| SCHEMBL22256070 | 0.81 | CYP1A2 (0.35) | PDK2CYP1A2CYP1B1 | |
| SCHEMBL25791417 | 0.81 | RARB (0.51) | RARBRARGRXRA | |
| SCHEMBL14508322 | 0.81 | ALDH1A1 (0.45) | PDK2 | |
| SCHEMBL28963933 | 0.80 | CYP1A2 (0.34) | PDK2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110054229-A1 | LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2011-03-03 | — | — | US | disclosed |
| US-20110054229-A1 | LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054229-A1 | LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME | OCIAD2, OCIAD1, ORMDL3 | PDK2 2238/4885RXFP1 4376/4885CYP1A2 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.